Private Equity Investors in Health & Wellness

Bain Capital Double Impact is the impact investing strategy of Bain Capital, focused on building market-leading companies that deliver both strong financial returns and measurable social and environmental impact. The platform leverages Bain Capital’s global reach and sector expertise to scale businesses across healthcare, sustainability, and inclusive growth. The firm partners with management teams to drive operational improvements, expand market reach, and embed impact into core business strategy. Its approach combines rigorous private equity discipline with a commitment to long-term, responsible value creation.

Better Society Capital is the UK’s leading social impact investor, focused on growing the flow of capital into solutions that address social challenges and inequalities. Established in 2012, the organization acts as a market builder, connecting investors, government, and social enterprises to scale impact investing across the UK. Rather than only deploying capital, Better Society Capital plays a catalytic role in developing the broader ecosystem, helping expand the UK impact investment market to over £11 billion while committing more than £1 billion directly into funds and enterprises.

Better Ventures is an early-stage impact venture capital firm investing in founders building solutions to some of the world’s most pressing challenges. The firm backs companies across climate, health, circular economy, PropTech, and sustainable consumer sectors, with a focus on scalable technologies that deliver measurable impact. Operating with an “impact + return” philosophy, Better Ventures supports entrepreneurs not just with capital, but with access to a curated network of operators, angels, and advisors. The firm positions founders as the drivers of change, helping them scale companies that generate both financial returns and meaningful environmental and social outcomes.

Pay it Forward Ventures (PIF) builds better lives for billions by investing in source-solving rather than symptom-solving. They fund and found ventures that create new paradigms across financial technology, health, energy, and digital infrastructure — and donate 20% of GP profits to philanthropy because they believe in paying it forward.